Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation.

Skerry C, Goldman WE, Carbonetti NH.

Infect Immun. 2019 Jan 24;87(2). pii: e00601-18. doi: 10.1128/IAI.00601-18. Print 2019 Feb.

PMID:
30510103
2.

Unprecedented in Vitro Antitubercular Activitiy of Manganese(II) Complexes Containing 1,10-Phenanthroline and Dicarboxylate Ligands: Increased Activity, Superior Selectivity, and Lower Toxicity in Comparison to Their Copper(II) Analogs.

McCarron P, McCann M, Devereux M, Kavanagh K, Skerry C, Karakousis PC, Aor AC, Mello TP, Santos ALS, Campos DL, Pavan FR.

Front Microbiol. 2018 Jul 2;9:1432. doi: 10.3389/fmicb.2018.01432. eCollection 2018.

3.

Fatal Pertussis in the Neonatal Mouse Model Is Associated with Pertussis Toxin-Mediated Pathology beyond the Airways.

Scanlon KM, Snyder YG, Skerry C, Carbonetti NH.

Infect Immun. 2017 Oct 18;85(11). pii: e00355-17. doi: 10.1128/IAI.00355-17. Print 2017 Nov.

4.

Reduction of Pertussis Inflammatory Pathology by Therapeutic Treatment With Sphingosine-1-Phosphate Receptor Ligands by a Pertussis Toxin-Insensitive Mechanism.

Skerry C, Scanlon K, Ardanuy J, Roberts D, Zhang L, Rosen H, Carbonetti NH.

J Infect Dis. 2017 Jan 15;215(2):278-286. doi: 10.1093/infdis/jiw536.

5.

TLR2-Modulating Lipoproteins of the Mycobacterium tuberculosis Complex Enhance the HIV Infectivity of CD4+ T Cells.

Skerry C, Klinkenberg LG, Page KR, Karakousis PC.

PLoS One. 2016 Jan 25;11(1):e0147192. doi: 10.1371/journal.pone.0147192. eCollection 2016.

6.

Novel therapies for the treatment of pertussis disease.

Scanlon KM, Skerry C, Carbonetti NH.

Pathog Dis. 2015 Nov;73(8):ftv074. doi: 10.1093/femspd/ftv074. Epub 2015 Sep 21. Review.

7.

Tuberculosis: An Inorganic Medicinal Chemistry Perspective.

Viganor L, Skerry C, McCann M, Devereux M.

Curr Med Chem. 2015;22(18):2199-224. Review.

PMID:
25850770
8.

Sphingosine-1-phosphate Receptor Agonism Reduces Bordetella pertussis-mediated Lung Pathology.

Skerry C, Scanlon K, Rosen H, Carbonetti NH.

J Infect Dis. 2015 Jun 15;211(12):1883-6. doi: 10.1093/infdis/jiu823. Epub 2014 Dec 23.

9.

Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Scanlon KM, Gau Y, Zhu J, Skerry C, Wall SM, Soleimani M, Carbonetti NH.

Infect Immun. 2014 Oct;82(10):4212-21. doi: 10.1128/IAI.02222-14. Epub 2014 Jul 28.

10.

Simvastatin increases the in vivo activity of the first-line tuberculosis regimen.

Skerry C, Pinn ML, Bruiners N, Pine R, Gennaro ML, Karakousis PC.

J Antimicrob Chemother. 2014 Sep;69(9):2453-7. doi: 10.1093/jac/dku166. Epub 2014 May 22.

11.

Vaccination with recombinant Mycobacterium tuberculosis PknD attenuates bacterial dissemination to the brain in guinea pigs.

Skerry C, Pokkali S, Pinn M, Be NA, Harper J, Karakousis PC, Jain SK.

PLoS One. 2013 Jun 11;8(6):e66310. doi: 10.1371/journal.pone.0066310. Print 2013.

12.

Adjunctive TNF inhibition with standard treatment enhances bacterial clearance in a murine model of necrotic TB granulomas.

Skerry C, Harper J, Klunk M, Bishai WR, Jain SK.

PLoS One. 2012;7(6):e39680. doi: 10.1371/journal.pone.0039680. Epub 2012 Jun 27.

13.

Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.

Harper J, Skerry C, Davis SL, Tasneen R, Weir M, Kramnik I, Bishai WR, Pomper MG, Nuermberger EL, Jain SK.

J Infect Dis. 2012 Feb 15;205(4):595-602. doi: 10.1093/infdis/jir786. Epub 2011 Dec 23.

14.

A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model.

Skerry CM, Mahon BP.

Clin Vaccine Immunol. 2011 Feb;18(2):187-93. doi: 10.1128/CVI.00371-10. Epub 2010 Dec 8.

15.

A live attenuated Bordetella pertussis candidate vaccine does not cause disseminating infection in gamma interferon receptor knockout mice.

Skerry CM, Cassidy JP, English K, Feunou-Feunou P, Locht C, Mahon BP.

Clin Vaccine Immunol. 2009 Sep;16(9):1344-51. doi: 10.1128/CVI.00082-09. Epub 2009 Jul 22.

Supplemental Content

Loading ...
Support Center